The efficient price: An opportunity for funding reform

Australian Health Review

Volumn 35, Issue 4, 2011, Pages 501-506

  Karnon, Jonathan ^a   Ben Tovim, David I ^b   Pham, Clarabelle T ^a   Caffrey, Orla ^c   Hakendorf, Paul H ^b   Crotty, Maria ^b   Phillips, Paddy A ^b,d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d SA Health   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82155163819     PISSN: 01565788     EISSN: 14498944     Source Type: Journal    
DOI: 10.1071/AH10966     Document Type: Article

References (8)

1. Council of Australian Governments Meeting 19-20 April 2010, Canberra Communiqué. COAG; 2010. Available at http://www.coag.gov.au/coag-meeting- outcomes/2010-04-19/docs/communique-20-April-2010.pdf [verified 1 November 2011].
2. Duckett SJ. Casemix funding for acute hospital inpatient services in Australia. Med J Aust 1998; 169: S17-21.
3. Duckett SJ. The development of Australian refined diagnosis related groups: The Australian inpatient casemix classification. Casemix Quarterly 2000; 2(4): 115-20.
4. PricewaterhouseCoopers, The review of the AR-DRG classification system development process. Department of Health and Ageing; 2009. Available at http://www.health.gov.au/internet/main/publishing.nsf/ Content/Casemix-1/ $File/Final-Report-November-2009.pdf [verified 19 October 2011].
5. van Hout BA, Al M, Gordon GS, Rutten FFH. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ 1994; 3: 309-19. doi:10.1002/ hec.4730030505
6. A national health and hospitals network for Australia's future: Delivering the reforms. Canberra: Commonwealth of Australia; 2010. Available at http://www.yourhealth.gov.au/internet/yourHealth/publishing.nsf/ Content/DeliveringTheReforms/$FILE/DeliveringTheReforms.pdf [verified 19 October 2011].
7. Karnon J, Brennan A, Akehurst RL. Decision modeling to inform decision making: Seeing the wood for the trees. Med Decis Making 2010; 30(3): E20-2. doi:10.1177/0272989X10364245
8. Sendi P, Gafni A, Birch S. Ethical economics and cost-effectiveness analysis: Is it ethical to ignore opportunity costs. Working Paper 02-05. Basel, Switzerland: Basel Institute for Clinical Epidemiology; 2005. Available at http://www.ceb-institute.org/uploads/media/WP-02-05.pdf [verified 19 October 2011].